Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II
Topical and systemic carbonic anhydrase inhibitors (CAIs) are widely used in the treatment of glaucoma for reducing intraocular pressure. This part of the review describes the characteristics of systemic CAIs, their side effects and the ways to overcome them, as well as contraindications. The use of...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2020-12-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/1357 |